Skip to content
lifestyle.utv.ie
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Ascelia Pharma
Ascelia Pharma Provides Orviglance(R) Update Following FDA Type a Meeting
October 11, 2026
Ascelia Pharma Announces Publication of Orviglance Clinical Study in Journal of Magnetic Resonance Imaging
September 24, 2026
Ascelia Pharma Completes FDA Type A Meeting on Orviglance NDA
September 10, 2026
Focus on The Path Forward for Orviglance
August 20, 2026
Ascelia Pharma Announces FDA Has Scheduled Type A Meeting for Orviglance NDA on September 9, 2026
August 17, 2026
Orviglance Data Presented Today at the Annual Radiology Congress ESGAR 2026
June 9, 2026
Quarterly Report Q1 2026: Orviglance(R) Approaching Transformative Milestones
May 12, 2026
Bulletin from the Annual General Meeting in Ascelia Pharma AB on 4 May 2026
May 5, 2026
Change in Number of Shares and Votes in Ascelia Pharma AB
May 4, 2026